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To our knowledge, detection of 
Bartonella spp. DNA in sea turtle 
blood represents the ﬁ  rst  molecular 
evidence of Bartonella infection in 
nonmammalian vertebrates. B. hense-
lae infection, now reported in porpois-
es and sea turtles, may represent an 
emerging infection of marine animals. 
According to previous studies, im-
mune status appears to affect disease 
severity, variation in clinical manifes-
tations, the pattern of histopathologic 
features, and the relative ease of diag-
nostic detection of the organism (4,7). 
Although healthy at the time of sample 
collection, the captive rehabilitated sea 
turtles were known to have been sick 
or injured before sampling, poten-
tially reﬂ  ecting immunocompromise. 
Whether detection of Bartonella spp. 
in blood of sea turtles is a function of 
prior immunosuppression induced by 
stressors is not known. Such stressors 
could include mechanical injury, mal-
nutrition, environmental toxins, para-
sites, or concurrent bacterial or viral 
infections. Alternatively, sea turtles 
may be a natural marine reservoir for 
B. henselae or for a Bartonella sp. ge-
netically related to B. vinsonii subsp. 
berkhofﬁ  i. 
In summary, documentation of B. 
henselae and an organism genetically 
similar to B. vinsonii subsp. berkhofﬁ  i 
in the blood of loggerhead sea turtles 
provides evidence that this genus is 
not ecologically limited to terrestrial 
reservoirs. The geographic distribu-
tion, prevalence of infection, carrier 
potential, mode of transmission, and 
pathogenicity of bloodborne Barton-
ella spp. in sea turtles await additional 
studies.
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Human Oestrus sp. 
Infection, Canary 
Islands
To the Editor: Myiasis due to 
Oestrus ovis is a well known zoonosis 
that affects a variety of animals. Hu-
man myiasis has also been described 
and affects mainly persons in rural 
areas such as shepherds (1) and farm-
ers (2). Although this disease has been 
reported in both humans and mam-
mals in Spain (3,4), no human case 
has been described on the Canary Is-
lands. We describe what we believe is 
the ﬁ  rst conﬁ  rmed case on the islands 
and discuss the potential utility of se-
rologic diagnosis for this disease. 
A 55-year-old farmer from the is-
land of El Hierro, with a medical his-
tory of hypercholesterolemia, Q fever, 
and murine typhus, but currently not 
being treated, consulted a physician in 
August 2005 concerning a wormlike 
sensation in his nose and sinuses that 
had lasted 2 days. Three days before 
noticing this sensation, he had been 
working in his neighbor’s barn, when 
he noticed that a passing ﬂ  y “dropped” 
something in his nose. He also reported 
sneezing and watery rhinorrhea. These 
symptoms were self-treated with nasal 
anticongestants, which provided tem-
porary relief. He ﬁ  nally sought medi-
cal attention when a severe cough de-LETTERS
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 6, June 2007  951 
veloped and the wormlike sensation 
extended to his throat.
On physical examination, the 
patient’s vital signs were normal, 
although a turbinate hypertrophy 
and mild redness of the throat were 
noted. No foreign objects or insects 
were seen on otorhinolaryngologic 
examination. The patient’s blood 
count showed 8,480 leukocytes/μL 
with 6.1% (520/μL) eosinophils. Be-
cause of his stated symptoms, myia-
sis was suspected, and symptomatic 
treatment was started, consisting of 
antihistamines, nasal anticongestants, 
cough suppressants, and asphyxiant 
methods, i.e., swallowed olive oil. 
The patient was monitored closely 
and had complete remission of his 
symptoms after 6 days. No relapse 
has occurred.
In the meantime, we discovered 
that a serologic test for O. ovis was 
available (5). We requested and ob-
tained a convalescent-phase serum 
sample from the patient on day 14 of 
his illness. Blood was also obtained 
from different “healthy” animals in 
the patient’s neighborhood, including 
2 dogs, 4 sheep, and 5 goats. This se-
rologic assay had not previously been 
used in testing humans. Excretory 
and secretory antigens from O. ovis 
L2 (OL2ES) were obtained as previ-
ously described (6), and samples were 
analyzed by an immune enzymatic as-
say technique (7). Appropriate testing 
with different dilutions of the antigens, 
sera, and immunoconjugates was con-
ducted. Immunoglobulin G (IgG) was 
detected in the patient, sheep, goats, 
and dogs following a similar proto-
col. OL2ES concentrations were 1, 1, 
3, and 5 μg/mL, respectively. Serum 
samples were diluted 1:100 for the 
patient and the dogs and 1:50 for the 
goats; immunoconjugates were dilut-
ed 1:1,500 for all species. O. ovis IgG 
was found in the patient’s sera, as well 
as in sera of the 2 dogs, 2 of 4 sheep, 
and all 5 goats (Table).
Human infection by O. ovis is 
generally considered to be an acciden-
tal occurrence (8). This case conﬁ  rms, 
however, that myiasis caused by O. 
ovis must be considered in the differ-
ential diagnosis of a patient with typi-
cal symptoms and eosinophilia. Most 
farmers in this area have reported sim-
ilar symptoms. Most, however, do not 
seek medical attention because they 
prefer to use homemade remedies, 
such as topical oil.
The diagnosis of oestrosis is usu-
ally made by direct visualization of 
the larvae, since the most frequent 
symptoms are pharyngeal myiasis and 
ophthalmomyiasis. Immunodiagnostic 
methods, however, could be a viable 
alternative to the clinical examina-
tion when no larvae are directly seen 
but a high degree of suspicion exists. 
The ELISA was noted to have a sen-
sitivity of 96.1% and a speciﬁ  city of 
55.8% (positive predictive value of 
86.7% and negative predictive value 
of 82.8%) in various investigations 
made with sheep and goats (6).
Although allergic symptoms are 
frequent in animals, the pathophysi-
ologic process seems to be different 
in humans (8). Nevertheless, other 
authors have also described coughing 
and sneezing (1), probably attributable 
to irritation of the mucosa. In animals, 
a primary peak in eosinophil numbers 
has been noted 4 days after infection 
with a primary increase 48 hours af-
ter infection (9). In humans this pat-
tern has not been described, but we 
did note a mild eosinophilia that dis-
appeared after the patient recovered 
from his symptoms.
Outcome of the disease in hu-
mans is generally benign. Treatment 
includes removal of the larvae and, in 
some cases, prevention of local infec-
tions. Ivermectin has also been found 
useful in animal and human infections 
(10).
To our knowledge, this is the ﬁ  rst 
case of human oestrosis on the Canary 
Islands, as well as the ﬁ  rst human case 
described with eosinophilia. Physi-
cians should be aware of the possibil-
ity of this disease in our region and of 
the fact that a serologic test is avail-
able for its diagnosis.
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Table. Results and interpretation, Oestrus sp. infection, Canary Islands*† 
Human Dogs Sheep Goats
OD Interpretation OD Interpretation OD Interpretation OD Interpretation
0.658 Positive 0.677 Positive 0.639 Positive 0.838 Positive
0.824 Positive 0.685 Positive 0.535 Positive
0.226 Negative 0.594 Positive
0.187 Negative 0.673 Positive
0.622 Positive
*Results are expressed as optical density (OD), and interpretation (positive/negative)  was made by using the following cut-offs: in sheep: 0.369 (0.1718 + 
3× 0.066); goats: 0.406 (0.211 + 3 × 0.065); human 0.32 (0.17 + 3 × 0.049); dogs: 0.493 (0.37 + 3 × 0.041). 
†One sample of positive and negative control samples was added to each plate. Sheep and goat sera from animals with a known history of O. ovis
exposure were used. When positive sera were not available (human and dogs), we used only negative sera, and the cut-off was estimated as the mean 
OD of the negative sera plus 3 SDs (7). LETTERS
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European 
Hedgehogs as 
Hosts for Borrelia 
spp., Germany 
To the Editor: The European 
hedgehog,  Erinaceus europaeus, is 
known to host a variety of tickborne 
pathogens, including the virus that 
causes tickborne encephalitis (1) and 
at least 3 species of the Borrelia burg-
dorferi sensu lato group: B. burgdorferi 
sensu stricto, B. afzelii, and B. garinii 
(2). Members of the B. burgdorferi s. 
l. group are the most common vector-
borne pathogens of humans in central 
Europe (3). The role of hedgehogs as 
hosts for these pathogens is, therefore, 
of considerable epidemiologic inter-
est. Hedgehogs are a common syn-
anthropic species that live in urban, 
suburban, and rural environments (4) 
and are known to carry not only the 
hedgehog tick, Ixodes hexagonus, but 
also the most common European tick, 
I. ricinus (2,5). Both of these ticks are 
known vectors of B. burgdorferi s. l. 
and tickborne encephalitis virus; I. 
ricinus is the most important vector of 
both throughout Europe (1,5). To date, 
however, only limited information 
has been available on the role of the 
hedgehog as a host or reservoir for B. 
burgdorferi s. l. in Germany.
We report the presence of 3 spe-
cies of the B. burgdorferi s. l. group in 
European hedgehogs from Germany. 
To our knowledge, this is the ﬁ  rst re-
port of these species in hedgehogs in 
this country and the ﬁ  rst report of B. 
spielmanii (A14S) (6) from this host.
The investigated hedgehogs came 
from 2 sources: 9 from the ≈40 in an 
experimental plot in the city of Karl-
sruhe, state of Baden-Wuerttemberg, 
and the remainder from wild hedge-
hogs that had been brought to hedge-
hog care centers from various areas 
of Germany. All hedgehogs had died 
naturally, and tissue samples were 
taken from 43 animals (kidneys from 
43, heart from 22, bladder from 33). 
The bodies had been frozen at –17°C 
before the samples were taken.
DNA isolation was done by using 
the Maxwell 16 Instrument and Sys-
tem (Promega, Madison, WI, USA). 
Tissue samples were 3×3×3 mm. To 
detect B. burgdorferi s. l., we used 2 
PCR protocols. The ﬁ  rst was a nested 
PCR done according to the method of 
Rijpkema et al. (7). The target for the 
PCR was the spacer region between 5S 
and 23S rRNA genes of B. burgdor-
feri s. l. The nested primers generated 
a product of 226 bp. The ampliﬁ  ed 
products were analyzed by agarose gel 
electrophoresis. The second protocol, 
a LightCycler-PCR hybridization as-
say (Roche Diagnostics, Mannheim, 
Germany) (8), simultaneously detects 
and genotypes the 3 genomic groups 
of B. burgdorferi s. l. This assay was 
speciﬁ  c for B. burgdorferi senso stric-
to, B. garinii, and B. afzelii (8) but also 
ampliﬁ  ed B. spielmanii and B. valai-
siana. The target for the PCR was the 
OspA gene.
The PCR products of both sys-
tems were sequenced. For DNA 
sequencing reaction, the ﬂ  uores-
cence-labeled didesoxynucleotide 
technology (Applied Biosystems, 
Darmstadt, Germany) was used. The 
sequenced fragments were separated, 
and the data were collected with an 
ABI PRISM  310 Genetic Analyzer 
(Applied Biosystems). The obtained 
sequences were then analyzed and 
compared by using BLAST (www.
ncbi.nlm.nih.gov/BLAST).
For 6 hedgehogs, Borrelia spp. 
could be clearly deﬁ  ned by using both 
gene sequences. Two additional ani-
mals had positive results, but sequenc-
ing was not possible because of either 
too little DNA or a mixed infection. 
B. spielmanii DNA was detected in 
the kidneys of 2 hedgehogs: 1 from 
Karlsruhe and 1 from 30 km west of 
this city in the German federal state of 
Rhineland-Palatinate. When sequenc-
es were compared by using BLAST, 
4 BLAST sequences (AM055823, 
AM055822, DQ133518, AY 995900) 